| SOP 8 updated |
|
|
 |
2020/07/30 |
| SOP 3,4, 7 and 8 updated |
|
|
|
2020/07/30 |
| General consultation on proposed changes to piperacillin-tazobactam breakpoints |
|
|
|
2020/07/17 |
| Consultation on proposed bacterial meningitis breakpoints |
|
|
|
2020/07/17 |
| Oral cephalosporins and Enterobacterales breakpoints - updated guidance document. |
|
|
|
2020/07/14 |
| SOP 9.2 and SOP 11.0 published |
EUCAST SOP 9.2 revised and SOP 11.0 published. |
|
|
2020/07/13 |
| Ceftolozane-tazobactam zone diameter breakpoints for H. influenzae available |
|
|
|
2020/06/16 |
| S.pneumoniae - panel of 10 strains with reference MICs available |
EUCAST and CCUG in collaboration have made a panel of 10 strains with reference MICs available. Strains were selected on the basis of the varying susceptibility to betalactam agents. |
|
|
2020/06/04 |
| Ceftolozane-tazobactam rationale document published |
|
|
|
2020/05/15 |
| EUCAST 2019 - 20. The chairman´s report. |
The EUCAST General Committee meeting at ECCMID 2020 was cancelled due to COVID19.
The EUCAST Steering Committee and subcommittees have, under the heading of the traditional Chairman´s report, summarised the last 12 months of activity. |
|
|
2020/05/04 |
| Cefiderocol breakpoints and AST methods |
Addendum to the EUCAST breakpoint table v 10.0: Cefiderocol breakpoints and AST methods (30 April, 2020) |
|
|
2020/04/30 |
| Rationale documents for amikacin, gentamicin and tobramycin updated |
|
|
|
2020/04/30 |
| EUCAST position paper on daptomycin in Enterococcal blood stream infections and endocarditis. |
Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper Clinical Microbiology and Infection, 2020. |
|
|
2020/04/28 |
| Warnings against gradient tests for piperacillin-tazobactam removed |
|
|
|
2020/04/24 |
| Aminoglycoside guidance document updated |
The guidance document on aminoglycoside dosing, first published 21 Jan, 2020, was updated 24 April, 2020. |
|
|
2020/04/24 |
| Temocillin breakpoints published |
|
|
|
2020/04/21 |
| Temocillin rationale document published |
|
|
|
2020/04/21 |
| RAST breakpoint table v 2.1 (as a substitute for 2.0) published |
Because of an error in the tab E. faecalis, a corrected version 2.1 is published. The only change is in the E.F faecalis tab. |
|
|
2020/04/20 |
| Aminoglycoside MIC distributions and ECOFFs reviewed in accordance with SOP 10.1 |
|
|
|
2020/04/12 |
| EUCAST instruction videos with Romanian subtitles |
|
|
|
2020/04/07 |
| Daptomycin and temocillin MIC data and ECOFFs reviewed |
|
|
|
2020/04/06 |
| EUCAST advice on intrinsic resistance and unusual phenotypes updated. |
|
|
|
2020/03/03 |
| EUCAST broth microdilution reading guide updated |
EUCAST broth microdilution reading guide updated to version 2.0 with specific reading instructions for Gram-negative organisms with tigecycline and eravacycline added. |
|
|
2020/03/02 |
| Quality of 21 brands of commercially available MH powders |
EUCAST has evaluated the quality of 21 Mueller Hinton powders, all commercially available. Several media performed well together with EUCAST criteria whereas others performed poorly. |
|
|
2020/02/29 |
| AFST - updated breakpoint tables |
|
|
|
2020/02/25 |
| AFST QC tables updated |
|
|
|
2020/02/25 |
| Rationale documents for antifungal agents updated |
|
|
|
2020/02/17 |
| Update: Breakpoint tables for Rapid AST directly from blood culture bottles |
|
|
|
2020/02/10 |
| RAST from blood culture bottles published |
|
|
|
2020/02/05 |
| New version of the ECOFFinder program available |
|
|
|
2020/01/26 |
| Guidance on the implementation and use of the 2020 revised aminoglycoside breakpoints (Jan 21, 2020) |
|
|
|
2020/01/21 |
| EUCAST/CLSI joint working group recommendations on the determination of appropriate disk content |
Consultation document with comments and responses published |
|
|
2020/01/10 |
| Guidance on Topical agents |
Revised guidance not on breakpoints for topical agents (valid from the 1 January, 2020) |
|
|
2019/12/31 |
| VetCast update on Steering Committee information |
|
|
|
2019/12/30 |
| EUCAST 2020 breakpoint tables available |
|
|
|
2019/12/20 |
| Updated guidance on methodological documents (disk testing, reading guide, media preparation) |
|
|
|
2019/12/20 |
| Consultation on ceftolozane-tazobactam concluded. |
Comments and EUCAST response released. |
|
|
2019/12/13 |
| EUCAST respons to comments during the temocillin consultation |
|
|
|
2019/12/09 |
| EUCAST Breakpoint table v 10.0 for consultation |
|
|
|
2019/12/06 |
| SOPs updated |
SOPs 1, 2, 5, 6 and 10 updated. |
|
|
2019/12/04 |
| Frequently Asked Questions - Mycobacteria |
A file with questions and answers was added |
|
|
2019/11/27 |
| ECOFFs for ceftolozane and ceftolozane-tazobactam added. |
|
|
|
2019/11/25 |
| Updated warnings |
Updated warnings and a new warning against the use of gradient tests for benzylpenicillin in S. pneumoniae issued. |
|
|
2019/11/21 |
| Workshop on generating phenotypic susceptibility data on MTBC |
|
|
|
2019/11/19 |
| Expert rules Enterococcus |
The document stated: "High level resistance reflect production of ANT(6) or other enzymes or of ribosomal mutations. In vitro studies have
shown lack of synergy of betalactams and gentamicin (now corrected to streptomycin) in such strains."
|
|
|
2019/11/07 |
| General consultation on revised ceftolozane-tazobactam breakpoints |
|
|
|
2019/11/01 |
| Cefazolin breakpoints in Enterobacterales in UTI - consultation until 8 November, 2019. |
|
|
|
2019/10/24 |
| Updated website statistics |
The use of EUCAST web pages reflects the adoption of EUCAST recommendations. Website statistics are updated on a regular basis. |
|
|
2019/10/17 |
| Frequently Asked Questions on EUCAST RAST |
|
|
|
2019/10/15 |
| Temocillin clinical breakpoints - consultation |
General consultation until 8 November, 2019, on proposed temocillin clinical breakpoints |
|
|
2019/10/14 |
